Rhoads Ann D insider trades
Rhoads Ann D has filed 37 Form 4s with the SEC that we hold, for QuidelOrtho Corp (QDEL) (Director), Globus Medical INC (GMED) (Director), ITOS (Director) and RPTX (Director), among 6 companies in all. Across all of them we count 1 purchase worth $21.2K and 5 sales worth $3.0M reported on Form 4. In the last 12 months: 1 purchase ($21.2K) and 2 sales ($818.0K). The largest single trade was a sale of 15,000 shares of Globus Medical INC worth $1.1M, dated 2024-09-13. The first filing on our record is dated 2021-07-23 and the latest 2026-06-29.
QuidelOrtho Corp (QDEL)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-12-10 | P, purchase reported on Form 4 | 750 | $21.2K | 2025-12-10 |
Globus Medical INC (GMED)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-09-13 | S, sale reported on Form 4 | 15,000 | $1.1M | 2024-09-17 |
| 2025-02-28 | S, sale reported on Form 4 | 7,500 | $590.1K | 2025-03-04 |
| 2025-09-15 | S, sale reported on Form 4 | 10,000 | $584.6K | 2025-09-16 |
| 2025-11-07 | S, sale reported on Form 4 | 8,000 | $648.0K | 2025-11-10 |
| 2025-11-10 | S, sale reported on Form 4 | 2,000 | $170.0K | 2025-11-10 |
ITOS
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
RPTX
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
QDEL (QDEL)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
EVOK
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1250252) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms